In the present study, we determined the feasibility of three genes (ERO1A, OSBPL3 and IFI44L) working as potential biomarkers in pancreatic ductal adenocarcinoma (PDAC). The gene discussed is OSBPL3; the disease is pancreatic ductal adenocarcinoma.